Cargando…

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

BACKGROUND: The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently characterized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seeliger, Hendrik, Pozios, Ioannis, Assmann, Gerald, Zhao, Yue, Müller, Mario H., Knösel, Thomas, Kreis, Martin E., Bruns, Christiane J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206939/ https://www.ncbi.nlm.nih.gov/pubmed/30373552 http://dx.doi.org/10.1186/s12885-018-4973-6

Ejemplares similares

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma
por: Lee, Lucas D., et al.
Publicado: (2022)

Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144
por: Pozios, Ioannis, et al.
Publicado: (2022)

Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
por: Pozios, Ioannis, et al.
Publicado: (2020)

Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer
por: Hering, Nina A., et al.
Publicado: (2023)

Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma
por: Hering, Nina A., et al.
Publicado: (2021)

Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
por: Schäfer, Claus, et al.
Publicado: (2012)

Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma
por: Younes, Mamoun, et al.
Publicado: (2018)

Estrogen adversely affects the prognosis of patients with lung adenocarcinoma
por: Hsu, Li-Han, et al.
Publicado: (2015)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
por: Gallmeier, Eike, et al.
Publicado: (2013)

Cancer Stem Cells in Pancreatic Cancer
por: Bao, Qi, et al.
Publicado: (2010)

THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA
por: EYFF, Tatiana Falcão, et al.
Publicado: (2018)

Risk factors for upper and lower type prolonged postoperative ileus following surgery for Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2021)

Estrogen receptor beta expression in prostate adenocarcinoma
por: Asgari, Mojgan, et al.
Publicado: (2011)

Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis
por: Pomianowska, Ewa, et al.
Publicado: (2014)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

Palliative Resection of Pancreatic Adenocarcinoma
por: Johnson, C. D.
Publicado: (1995)

Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma
por: Popp, Felix C., et al.
Publicado: (2021)

Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging
por: Loch, Florian N., et al.
Publicado: (2020)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma
por: Ren, Hu, et al.
Publicado: (2020)

Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
por: Park, Sejun, et al.
Publicado: (2023)

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)

Clinical Predictors of Resectability of Pancreatic Adenocarcinoma
por: Almadi, Majid A., et al.
Publicado: (2013)

Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2016)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2018)

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
por: Li, Xiaojie, et al.
Publicado: (2020)

Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures
por: Zou, Xuan, et al.
Publicado: (2023)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
por: Azizan, Nornazirah, et al.
Publicado: (2018)

Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses
por: Ivanova, MM, et al.
Publicado: (2011)

Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma
por: Speichinger, Fiona, et al.
Publicado: (2021)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
por: Botsis, Taxiarchis, et al.
Publicado: (2010)

Resected pancreatic adenocarcinoma: An Asian institution's experience
por: Ng, Kennedy Yao Yi, et al.
Publicado: (2021)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma
por: Heredia-Soto, Victoria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_op5uipmst6cq4l4mnpanumqc5e